rs402691

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002739.5(PRKCG):​c.286-1255T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.389 in 151,784 control chromosomes in the GnomAD database, including 13,342 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 13342 hom., cov: 32)

Consequence

PRKCG
NM_002739.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.36

Publications

2 publications found
Variant links:
Genes affected
PRKCG (HGNC:9402): (protein kinase C gamma) Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play distinct roles in cells. The protein encoded by this gene is one of the PKC family members. This protein kinase is expressed solely in the brain and spinal cord and its localization is restricted to neurons. It has been demonstrated that several neuronal functions, including long term potentiation (LTP) and long term depression (LTD), specifically require this kinase. Knockout studies in mice also suggest that this kinase may be involved in neuropathic pain development. Defects in this protein have been associated with neurodegenerative disorder spinocerebellar ataxia-14 (SCA14). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PRKCG Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 14
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002739.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.04).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.628 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002739.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKCG
NM_002739.5
MANE Select
c.286-1255T>C
intron
N/ANP_002730.1P05129-1
PRKCG
NM_001316329.2
c.286-1255T>C
intron
N/ANP_001303258.1A0A804HIU5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKCG
ENST00000263431.4
TSL:1 MANE Select
c.286-1255T>C
intron
N/AENSP00000263431.3P05129-1
PRKCG
ENST00000682028.1
c.286-1255T>C
intron
N/AENSP00000507230.1A0A804HIU5
PRKCG
ENST00000683513.1
c.286-1255T>C
intron
N/AENSP00000506809.1A0A804HHY0

Frequencies

GnomAD3 genomes
AF:
0.389
AC:
58974
AN:
151666
Hom.:
13298
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.634
Gnomad AMI
AF:
0.342
Gnomad AMR
AF:
0.372
Gnomad ASJ
AF:
0.388
Gnomad EAS
AF:
0.312
Gnomad SAS
AF:
0.370
Gnomad FIN
AF:
0.226
Gnomad MID
AF:
0.383
Gnomad NFE
AF:
0.277
Gnomad OTH
AF:
0.407
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.389
AC:
59076
AN:
151784
Hom.:
13342
Cov.:
32
AF XY:
0.385
AC XY:
28539
AN XY:
74182
show subpopulations
African (AFR)
AF:
0.635
AC:
26191
AN:
41264
American (AMR)
AF:
0.372
AC:
5667
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.388
AC:
1345
AN:
3466
East Asian (EAS)
AF:
0.312
AC:
1615
AN:
5180
South Asian (SAS)
AF:
0.371
AC:
1787
AN:
4816
European-Finnish (FIN)
AF:
0.226
AC:
2382
AN:
10544
Middle Eastern (MID)
AF:
0.374
AC:
110
AN:
294
European-Non Finnish (NFE)
AF:
0.277
AC:
18800
AN:
67948
Other (OTH)
AF:
0.411
AC:
868
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1700
3401
5101
6802
8502
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
544
1088
1632
2176
2720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.327
Hom.:
1247
Bravo
AF:
0.412
Asia WGS
AF:
0.381
AC:
1325
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.083
DANN
Benign
0.28
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs402691;
hg19: chr19-54391637;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.